Please join for us for a discussion of next steps in the PDUFA reauthorization process, including PDUFA VI priorities for the patient community and the biopharmaceutical industry.
Registration is closed. This event has already been held.
PDUFA 201 Briefing950 F St NW, Suite 300, Washington, DC, 20004, US